Produktbild: Lung Cancer and Personalized Medicine

Lung Cancer and Personalized Medicine

Lieferzeit: Lieferbar innerhalb 14 Tagen

106,99 €

inkl. 7 % MwSt. zzgl. Versandkosten

Current Knowledge and Therapies, Advances in Experimental Medicine and Biology 893

ISBN: 3319242210
ISBN 13: 9783319242217
Herausgeber: Aamir Ahmad/Shirish Gadgeel
Verlag: Springer Verlag GmbH
Umfang: xiii, 228 S., 12 s/w Illustr., 14 farbige Illustr., 228 p. 26 illus., 14 illus. in color.
Erscheinungsdatum: 18.12.2015
Auflage: 1/2016
Produktform: Gebunden/Hardback
Einband: Gebunden

This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer-statistics and epidemiology of lung cancer-along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer-immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies.

Artikelnummer: 8473526 Kategorie:

Beschreibung

Herstellerkennzeichnung:


Springer Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

E-Mail: juergen.hartmann@springer.com

Das könnte Ihnen auch gefallen …